首页> 美国卫生研究院文献>PLoS Clinical Trials >Pathogen Proteins Eliciting Antibodies Do Not Share Epitopes with Host Proteins: A Bioinformatics Approach
【2h】

Pathogen Proteins Eliciting Antibodies Do Not Share Epitopes with Host Proteins: A Bioinformatics Approach

机译:病原体抗体淘汰抗体不与宿主蛋白质共享表位:一种生物信息学方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The best way to prevent diseases caused by pathogens is by the use of vaccines. The advent of genomics enables genome-wide searches of new vaccine candidates, called reverse vaccinology. The most common strategy to apply reverse vaccinology is by designing subunit recombinant vaccines, which usually generate an humoral immune response due to B-cell epitopes in proteins. A major problem for this strategy is the identification of protective immunogenic proteins from the surfome of the pathogen. Epitope mimicry may lead to auto-immune phenomena related to several human diseases. A sequence-based computational analysis has been carried out applying the BLASTP algorithm. Therefore, two huge databases have been created, one with the most complete and current linear B-cell epitopes, and the other one with the surface-protein sequences of the main human respiratory bacterial pathogens. We found that none of the 7353 linear B-cell epitopes analysed shares any sequence identity region with human proteins capable of generating antibodies, and that only 1% of the 2175 exposed proteins analysed contain a stretch of shared sequence with the human proteome. These findings suggest the existence of a mechanism to avoid autoimmunity. We also propose a strategy for corroborating or warning about the viability of a protein linear B-cell epitope as a putative vaccine candidate in a reverse vaccinology study; so, epitopes without any sequence identity with human proteins should be very good vaccine candidates, and the other way around.
机译:预防由病原体引起的疾病的最佳方法是使用疫苗。基因组学的出现使得能够在全基因组范围内搜索新的候选疫苗,称为反向疫苗学。应用反向疫苗学的最常见策略是设计亚单位重组疫苗,该疫苗通常由于蛋白质中的B细胞表位而产生体液免疫反应。该策略的主要问题是从病原体表面鉴定保护性免疫原性蛋白质。表位模仿可能导致与几种人类疾病相关的自身免疫现象。应用BLASTP算法进行了基于序列的计算分析。因此,已经建立了两个庞大的数据库,一个数据库具有最完整和最新的线性B细胞表位,另一个数据库具有人类主要呼吸道细菌病原体的表面蛋白序列。我们发现,所分析的7353个线性B细胞表位中没有一个与能够产生抗体的人蛋白质共享任何序列同一性区域,并且所分析的2175个暴露蛋白质中只有1%与人蛋白质组共享了一段共享序列。这些发现表明存在避免自身免疫的机制。我们还提出了一种策略,用于在反向疫苗学研究中证实或警告蛋白质线性B细胞表位作为推定疫苗候选物的可行性;因此,与人蛋白质没有任何序列同一性的表位应该是非常好的候选疫苗,反之亦然。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号